S526Referred to Committee

Pharmacy Benefit Manager Transparency Act of 2025

Share:
Introduced
In Committee
3
Passed One Chamber
4
Passed Both
5
Signed into Law
119th
Congress
2025-02-11
Introduced
14
Cosponsors
S
ⓘ
Type

Sponsor

Chuck Grassley
Chuck Grassley
Republican · IA · Senator
Votes with party: 35.4% (322 recorded votes)

Full profile: /officials/G000386

Source: Congress.gov · FEC

Cosponsors (14)

Members who have signed on to support this bill since introduction. Source: Congress.gov.

Latest Action

The most recent step in the bill's legislative path. Committee Activity below shows referrals and reports; the full action-by-action history including floor proceedings lives at Congress.gov →

Read twice and referred to the Committee on Commerce, Science, and Transportation.

2025-02-11

Source: Congress.gov

Committee Activity

Currently in

Previously

Plain-English Summary

This bill would require pharmacy benefit managers—the companies that manage prescription drug benefits for insurance plans—to disclose more information about how they set drug prices, negotiate with pharmacies, and handle patient costs. The goal is to give patients, doctors, and regulators better visibility into why prescription drugs cost what they do and how much money these middlemen are making from the system. The changes would mainly affect health insurance companies, pharmacies, and the pharmacy benefit managers themselves.

AI-assisted summary generated from the official bill metadata (title, subjects, actions) sourced from Congress.gov. Cached and reviewed. Always verify against the official text linked below.

Subjects

Health
Full bill text is not yet cached locally.
Open text viewRead on Congress.gov

Related legislation

Bills by the same sponsor or covering overlapping subjects.